Could not find the what you are looking for?
Regulatory Filings
Regulatory Filings
- Board Decisions – 6th November 2024
- Board Decisions – 13th August 2024
- Investor Call Invite – 14th August 2024
- Outcome of the Board Meeting – 30th May 2024
- Transcript – Investor Call – 27th April 2024
- Audio Recordings of Investors Call – 27th April 2024
- Outcome of the Board Meeting- 26th April 2024
- Investor Call Invite (revised) – 27th April 2024
- Investor Call Invite – 27th April 2024
- Investor Presentation – 26th April 2024
- Reg 30 Disclosure – intimation of changes in senior management personnel – 19th March 2024
- Investor Presentation – 8th February 2024
- Press Release – 8th February 2024
- Intimation of consideration of Interim Dividend
- Board Decisions – 08th Feb 2024
- compliance under Reg 52_54
- Investors Concall Invite Revised – 24th Jan 2024 – 3rd February 2024
- Investors Concall Invite – 24th January 2024
- Notice of Board Meeting – 17th January 2024
- Reg_57(1)_Disclosure – 12th January 2024
- Statement under Reg 13(3) for the quarter ended 31st December 2023
- Reg 30 Disclosure_Intimation of change in shareholding in AHHL – 27th December 2023
- Intimation of Trading Window – 22nd December 2023
- Specification_Debt_ISIN_Details – 16th November 2023
- Compliance under 52_54 – 9th November 2023
- Statement under Regulation 13(3) for the quarter ended 30th September 2023
- Notice of Record date
- Active ISIN-30th September 2023
- Investor Presentation – 9th November 2023
- Board Decisions – 9th November 2023
- Investor Concall Invite – 3rd November 2023
- Credit Rating Letter – 28th October 2023
- Notice of the Board Meeting – 28th October 2023
- Press Release – Kolkata – 27th September 2023
- Intimation Trading Window – 26th September 2023
- Reg 30 disclosure – Appointment of Senior Management Personnel 19th September 2023
- Voting Results – AGM 30th August 2023
- Investor Presentation – 11th August 2023
- Board Decisions 11th August 2023
- Investors Concall Invite – 9th August 2023
- Notice of Board Meeting – 17th July 2023
- compliance under Reg57(5) 3rd July 2023
- Statement under Regulation 13(3) for the quarter ended 30th June 2023
- caption Intimation of Trading Window_June 2023
- compliance under Reg57(4) 21st June 2023
- Intimation reg.change in AGM Date – 2nd June 2023
- Outcome Analyst Call – 31st May 2023
- Compliance Under 52_54 – 30th May 2023
- Investor Presentation – 30th May 2023
- Press Release – 30th May 2023
- Investors call invite 25th May 2023
- compliance under Reg57(4) 21st Mar 2023
- Half Yearly Disclosures on RPT 31st March 2023
- Statement under Regulation 13(3) for the quarter ended 31st Mar 2023
- Intimation Trading Window – 27th Mar 2023
- Secretarial Compliance Report – March 2023
- compliance under Reg 57(5) March 2023
- Annual Disclosure Large Entity March 2023
- Board Decisions 30th May 2023
- Notice of Board Meeting 8th May 2023
- record date revised intimation 16th Feb 2023
- Board Decisions – 14th February 2023
- compliance under 52_54 – 14th Feb 2023
- Investor Presentation – 14th Feb 2023
- Notice of Board Meeting – 31st Jan 2023
- compliance under Reg57(1) 12th Jan 2023
- Statement under Regulation 13(3) for the quarter ended 31st Dec 2022
- Intimation Trading Window – 26th Dec 2022
- compliance under Reg57(4) 24th Dec 2022
- Notice of Record Date 20th Dec 2022
- Allotment of NCDs 14th Dec 2022
- Notice of Unsecured Debentures 6th Dec 2022
- Reg 30 disclosure – Letter of comfort – 6th Dec 2022
- Board Decisions – 30th November 2022
- Notice of the Board Meeting 26th November 2022
- Half Yearly Disclosures on RPT 30th September 2022
- Investor Presentation – 12th November 2022
- Investors call invite 11th Nov 2022
- Board Decisions – 10th November 2022
- Investor Call Invite – 31st October 2022
- Notice of the Board Meeting 14th October 2022
- Statement under Regulation 13(3) for the quarter ended 30th Sept 2022
- Intimation Acquisition of AyurVaid Hospitals
- Intimation Trading Window – 29th September 2022
- Voting Results – AGM 25th August 2022
- Investor Presentation – 12th August 2022
- Board Decisions – 11th August 2022
- Investor Call Invite – 9th August 2022
- Acquisition of 650 bed hsopital facility Gurgaon 8th August 2022
- Notice of the Board Meeting 26th July 2022
- Board Decisions – 16th July 2022
- Statement under Regulation 13(3) for the quarter ended 30th June 2022
- Intimation Trading Window – 27th June 2022
- Investor Presentation – 26th May 2022
- Board Decisions – 25th May 2022
- Investor Call Invite – 23rd May 2022
- Annual Disclosure – Large Entity- 14th May 2022
- Initial Disclosure – Large Entity – 29th April 2022
- Notice of the Board Meeting 25th April 2022
- Statement under Regulation 13(3) for the quarter ended 31st March 2022
- Half Yearly Disclosures on RPT 31st March 2022
- Intimation Trading Window – 26th March 2022
- Intimation effective date transfer of undertaking 16th March 2022
- Intimation-Regulation 57(1) NCD payment 8th Mar 2022
- Regulation 52(7) 14th Feb 2022
- Investor Presentation 12th Feb 2022
- Board Decisions – 11th February 2022
- Investors call invite 10th Feb 2022
- Investor Call Invite – 8th Feb 2022
- Intimation Record NCD 5th Feb 2022
- Investor Call Invite – 4th Feb 2022
- Intimation credit rating 31st Jan 2022
- Investors call invite 28th Jan 2022
- Intimation upcoming launch amazon 28th Jan 2022
- Notice of the Board Meeting 24th Jan 2022
- Statement under Regulation 13(3) for the quarter ended 31st December 2021
- Intimation of Closure of Trading Window 22nd Dec 2021
- Voting Results Director appointment 21st Dec 2021
- Notice of Postal Ballot 18th November 2021
- Investor Presentation 13th November 2021
- Board Decisions – 12th November 2021
- Investors call invite 10th November 2021
- Notice of the Board Meeting 25th Oct 2021
- Statement under Regulation 13(3) for the quarter ended 30th September 2021
- Half Yearly disclosures RPT 30th Sept 2021
- Intimation of Closure of Trading Window 30th Sep 2021
- Voting Results – AGM – 31st August 2021
- Voting Results slumpsale backendpharmacy 14th August 2021
- Investor Presentation 13th August 2021
- Board Decisions – 13th August 2021
- Investors call invite 12th August 2021
- Notice of the Board Meeting 03rd August 2021
- Board Decisions 21st July 2021
- Notice of Postal Ballot 13th July 2021
- QIP-PPD Jan 2021
- Pharmacy Restructuring
- Execution of BTA – 1st July 2021
- Intimation of Closure of Trading Window – 30th June 2021
- Confirmation of order of Scheme of Amalgamation – 30th June 2021
- Statement under Regulation 13(3) for the quarter ended 30th June 2021
- Certificate under Regulation 52(5) 28th June 2021
- Certificate compliance 57(2) 24th June 2021
- Investor call invite presentation 23rd June 2021
- Board Decisions – 23rd June 2021
- Notice of the Board Meeting – 08th June 2021
- Annual Disclosure – Large Entity – 15th May 2021
- Voting Results – merger – 4th May 2021
- Initial Disclosure – Large Entity – 30th April 2021
- Notice of acquisition – 22nd April 2021
- Half Yearly Disclosures on RPT 31st March 2021
- Statement under Regulation 13(3) for the quarter ended 31st March 2021
- Notice of Postal Ballot – 31st March 2021
- Intimation of Closure of Trading Window – 29th March 2021
- Board Decisions – 27th March 2021
- Intimation of Record Date – 8th February 2021
- Intimation – Scheme of Amalgamation – 28th January 2021
- Notice of the Board Meeting – 28th January 2021
- Committee Decisions – 23rd January 2021
- Committee Decisions – 22nd January 2021
- Board Decisions – 18th January 2021
- Notice of the Committee Meeting – 18th January 2021
- Intimation of Notice of investor meetings – 11th January 2021
- Intimation of Notice of investor meetings – 6th January 2021
- Statement under Regulation 13(3) for the quarter ended 31 December 2020
- Board Decisions – 2nd December 2020
- Intimation of Closure of Trading Window – December 2020
- Notice – 7th December 2020
- Notice of the Board Meeting – 7th November 2020
- Notice of the Board Meeting – 2nd November 2020
- Half Yearly Disclosures on RPT-30th September 2020
- Statement under Regulation 13(3) for the quarter ended 30th September 2020
- Board Decisions – December 2020
- Voting Results QIP 2020
- Board Decision – November 2020
- Intimation of Closure of Trading Window – September 2020
- Voting Results 2020
- Board Decision – September 2020
- Half Yearly Disclosure on Related Party Transactions – 31st March 2020
- Intimation of sanction of Scheme of Arrangement by NCLT
- Notice for Board Meeting
- Intimation of effective date of Scheme of Arrangement
- Call Option Notice – NCDs
- Intimation Record Date – NCDs
- Statement under Regulation 13(3) for the quarter ended 30th June 2020
- Intimation of Closure of Trading Window – June 2020
- Board Decisions – June 2020
- Notice of Board Meeting – Revised Date
- Notice of Board Meeting
- Intimation of Closure of Trading Window
- Statement under Regulation 13(3) for the quarter ended 31st March 2020
- Notice for Board Meeting
- Notice for Board Meeting
- Statement under Regulation 13(3) for the quarter ended 31st December 2019
- Statement under Regulation 13(3) for the quarter ended 30th September 2019
- Statement under Regulation 13(3) for the quarter ended 30th June 2019
- Board Decisions – February 2020
- Half Yearly Disclosure on Related Party Transactions – 30th September 2019
- Board Decisions – November 2019
- Board Decisions – August 2019
- Half Yearly Disclosure on Related Party Transactions – 31st March 2019
- Notice for Board Meeting
- Intimation to Stock Exchange – Apollo Munich Health Insurance Company Limited
- Complaint Report NSE
- Complaint Report BSE
- Financial Results – March 2019
- Notice for Board Meeting
- Intimation of Record Date – NCD-7104, Aug 2018
- Intimation of Record Date – NCD-7104, Jul 2018
- Intimation of Record Date – NCD 7112
- Intimation of Record Date – NCD 7120
- Notice of Board Meeting – August 2018
- Notice of Board Meeting – February 2019
- Notice of Board Meeting – May 2018
- Notice of Board Meeting – November 2018
- Intimation to Stock Exchange – Change in Directors
- Intimation regarding Scheme of Arrangement – AHEL and Apollo Pharmacies Limited
- Board Decisions – February 2019
- Board Decisions – November 2018
- Intimation regarding resignation of 2 Independent Directors
- Voting Results 2017
- Intimation of interest payment of NCDs
- Notice of Board Meeting – November 2016
- Financial Results – November 2016
- Intimation of Record date for Non convertible Debentures
- Notice of Board Meeting – January 2017
- Disclosure under Regulation 30
- Intimation of Record Date of NCDs – Rs. 50 crores
- Intimation of Record Date of NCDs – Rs. 94 crores
- Intimation of Interest payment
- Disclosure under Regulation 30(1) & 30(2) of SEBI SAST
- Notice of Board Meeting – May 2017
- Intimation of unaudited Financial Results – Q1, FY 2017
- AGM Proceeding Voting Results 2016
- Certificate under Regulation 52 (5) of SEBI
- Compliance under Regulation 57 (2) of SEBI
- Letters to stock exchanges
- Audited Financial Results – FY 2016
- Notice for Board Meeting
- Reconciliation of share capital audit report for the quarter ended 31st March 2016
- Certificate under Regulation 40(9)
- Investor complaints statement as on 31st March 2016
- Disclosure under Regulation 30(1) of SEBI LODR
- Disclosure under Regulation 31
- Payment Letter
- Disclosure SE Letters
- Disclosure
- Dividend Communication
- Intimation of Record Date
- Stock Communication
- Notice of Board Meeting
- NCD Interest Intimation
- Half year communication
